Treatment Patterns and Survival Outcomes of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer Survival at a Safety-Net Hospital

被引：0
|
作者：
Sabloak, Krishti [1 ]
Derton, Abigail [2 ]
Teigen, Kari [2 ]
Gonzales, Mario [3 ]
Ghabach, Bassam [3 ]
Narra, Kalyani [3 ]
机构：
[1] UNT Hlth Sci Ctr, Ft Worth, TX USA
[2] JPS Hlth Network, Off Clin Res, Ft Worth, TX USA
[3] JPS Hlth Network, JPS Oncol & Infus Ctr, Ft Worth, TX USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP01.40
引用
收藏
页码：E22 / E22
页数：1
相关论文
共 50 条
  • [1] Immune checkpoint inhibitors in advanced non-small cell lung cancer: Real-world survival and safety
    Tang, Monica
    Lee, Chee
    Lewis, Craig
    Boyer, Michael
    Brown, Bernadette
    Schaffer, Andrea
    Pearson, Sallie-Anne
    Simes, Robert
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 30 - 31
  • [2] Modeling Survival Outcomes of Immune Checkpoint Inhibitors on Locally Advanced Non-Small Cell Lung Cancer Following Concurrent Chemoradiotherapy
    Huang, H. T.
    Hawkins, M. A.
    Fenwick, J. D.
    Nix, M. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E375 - E375
  • [3] Restricted mean survival time in advanced non-small cell lung cancer treated with immune checkpoint inhibitors
    Di Spazio, L.
    Cancanelli, L.
    Rivano, M.
    Chiumente, M.
    Mengato, D.
    Messori, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (04) : 1881 - 1889
  • [4] Immune checkpoint inhibitors in advanced non-small cell lung cancer
    Fabre, Elizabeth
    Pecuchet, Nicola
    Cadranel, Jacques
    BULLETIN DU CANCER, 2016, 103 : S138 - S143
  • [5] Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
    Assi, Hazem I.
    Kamphorst, Alice O.
    Moukalled, Nour M.
    Ramalingam, Suresh S.
    CANCER, 2018, 124 (02) : 248 - 261
  • [6] Survival and biomarkers for cachexia in non-small cell lung cancer receiving immune checkpoint inhibitors
    Murata, Daiki
    Azuma, Koichi
    Matsuo, Norikazu
    Murotani, Kenta
    Matama, Goushi
    Kawahara, Akihiko
    Sasada, Tetsuro
    Tokito, Takaaki
    Hoshino, Tomoaki
    CANCER MEDICINE, 2023, 12 (19): : 19471 - 19479
  • [7] Survival outcomes of patients with non-small cell lung cancer concomitantly receiving proton pump inhibitors and immune checkpoint inhibitors
    Baek, Yeon-Hee
    Kang, Eun Joo
    Hong, Soojung
    Park, So-Hee
    Kim, Ju Hwan
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 347 - 347
  • [8] Survival outcomes of patients with non-small cell lung cancer concomitantly receiving proton pump inhibitors and immune checkpoint inhibitors
    Baek, Yeon-Hee
    Kang, Eun Joo
    Hong, Soojung
    Park, So-Hee
    Kim, Ju Hwan
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 409 - 410
  • [9] The impact of beta blockers on survival outcomes in non-small cell lung cancer patients treated with immune checkpoint inhibitors
    Oh, Michael
    Oh, Michael
    Guzner, Alex
    Wainwright, Derek
    Mohindra, Nisha
    Chae, Young Kwang
    Behdad, Amir
    Villaflor, Victoria
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [10] Survival of Patients with Early-Stage Non-Small Cell Lung Cancer (NSCLC) Diagnosed at a Safety-Net Hospital (SNH)
    Reddy, Priyanka
    Derton, Abigail
    Teigen, Kari
    Jensen, Carissa
    Johnson, Raymond
    Ghabach, Bassam
    Narra, Kalyani
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E59 - E60
12345